A cutoff level is the concentration, measured in nanograms per milliliter (ng/mL), that a lab uses to decide whether a urine specimen reports negative or moves forward for confirmation. Under federal rules, the initial screening cutoff for marijuana metabolite (THCA) is 50 ng/mL, dropping to 15 ng/mL for confirmation; benzoylecgonine (the cocaine metabolite) sits at 150 ng/mL initial and 100 ng/mL confirmatory. These figures come from 49 CFR § 40.85, the regulation that governs federally mandated drug testing, backed by SAMHSA/HHS guidance.
TL;DR:
- Federal initial screening cutoffs are set at 50 ng/mL for marijuana and 150 ng/mL for cocaine, with confirmatory levels generally lower to ensure specificity.
- Confirmatory tests use GC-MS or LC-MS/MS, which set lower thresholds and confirm true positives by identifying specific molecules rather than cross-reacting substances.
- Specimen validity is checked with parameters like creatinine and specific gravity, while adulteration is flagged by pH and oxidant levels, affecting test legitimacy.
- Licensed physicians called medical review officers verify positive results, considering prescriptions and context, to prevent false accusations of drug use.
- Detection windows vary by drug and individual factors, with marijuana lasting days to weeks, while cocaine and opioids are typically detectable for one to four days.
Table of Contents
- What Are the Official Urine Test Cutoff Levels?
- How Do Screening and Confirmation Tests Differ?
- What Makes a Urine Specimen Invalid or Adulterated?
- What Does a Medical Review Officer Actually Verify?
- What Detection Window and Concentration Factors Matter?
- Quick Reference: Common Analyte Cutoffs
- Why Cutoff Numbers Matter in Court and Diversion Cases
- Getting Court-Ready Documentation Without the Guesswork
- Sources
- FAQ
What Are the Official Urine Test Cutoff Levels?
Federal cutoff levels aren’t arbitrary. They come from decades of toxicology data balancing two competing risks: flagging someone who never used a drug (false positive) and clearing someone who did (false negative). The eCFR’s Part 40.85 sets the cutoffs used across federally regulated transportation testing, and the U.S. Department of Transportation republishes the same table on its own ODAPI guidance page.
Here’s how the core numbers break down for the analytes most commonly tested:
| Analyte | Initial Cutoff (ng/mL) | Confirmatory Cutoff (ng/mL) |
|---|---|---|
| THCA (marijuana metabolite) | 50 | 15 |
| Benzoylecgonine (cocaine) | 150 | 100 |
| Codeine/Morphine | 2,000 | 2,000 |
| Hydrocodone/Hydromorphone | 300 | 100 |
| Oxycodone/Oxymorphone | 100 | 100 |
| 6-Acetylmorphine (heroin marker) | 10 | 10 |
| PCP | 25 | 25 |
| Amphetamine/Methamphetamine | 500 | 250 |
| MDMA/MDA | 500 | 250 |
The logic runs in one direction only. A specimen measuring below the initial cutoff is reported negative, period. One that meets or exceeds the initial cutoff doesn’t get reported positive outright. It moves to a confirmatory test, almost always gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS), which uses a separate, generally lower cutoff. Only a result at or above that confirmatory threshold counts as confirmed positive.
Morphine and codeine carry an added twist: labs must report a specific quantitative value once concentrations hit 15,000 ng/mL or higher, a detail the DOT spells out in its own Part 40.85 guidance. That number matters later when a medical review officer has to weigh dietary poppy seed exposure against genuine opioid use.
Program differences matter too. DOT-regulated testing (trucking, aviation, rail) follows this exact table. HHS/SAMHSA’s mandatory guidelines apply the same baseline to federal workplace programs, while private clinical labs and court-ordered testing sometimes use different validated cutoffs for the same analyte, so the governing program always determines which numbers actually apply.
How Do Screening and Confirmation Tests Differ?
Initial screens rely on immunoassay technology, cheap, fast, and deliberately set with a higher cutoff to keep false positives from clogging up the confirmatory lab queue. The tradeoff is precision: immunoassays cross-react with structurally similar compounds, so a screen can’t tell you exactly what’s in the specimen, only that something crossed the line.
Confirmatory testing fixes that with GC-MS or LC-MS/MS, methods that identify and quantify the exact molecule present. That’s why confirmatory cutoffs run lower for most analytes, THCA drops from 50 to 15 ng/mL, benzoylecgonine from 150 to 100. Lower confirmatory cutoffs work because the method itself is more specific, not less careful.
A handful of analytes break that pattern. PCP, 6-AM, and oxycodone/oxymorphone all use the same number for both stages:
- PCP: 25 ng/mL initial and confirmatory
- 6-AM (heroin marker): 10 ng/mL initial and confirmatory
- Oxycodone/oxymorphone: 100 ng/mL initial and confirmatory
Regulators set these “alternate technology” exceptions where the initial assay is already specific enough that a lower confirmatory threshold wouldn’t add meaningful accuracy, according to the NCBI reference tables that corroborate the federal figures.
What Makes a Urine Specimen Invalid or Adulterated?
Before a lab even runs the drug panel, it screens the specimen itself. DOT rules under § 40.86 require labs to check creatinine, specific gravity, pH, and oxidant or nitrite levels on every sample.
A few thresholds come up constantly in specimen-validity findings:
- Dilute specimens: creatinine between 2 and 20 mg/dL combined with specific gravity between 1.0010 and 1.0030 signals a dilute sample.
- Substituted specimens: creatinine below 2 mg/dL paired with specific gravity below 1.0010 or above 1.0200 indicates the fluid likely isn’t human urine.
- Adulterated specimens: pH below 4.0 or above 11.0, or detectable oxidants/nitrites (like bleach or nitrite additives) above validated cutoffs, flags tampering.
Pro Tip: If your specimen comes back “dilute,” that alone usually doesn’t equal a positive or a violation, but under DOT rules it can trigger an immediate recollection under direct observation, so don’t assume a dilute result closes the matter.
Labs report adulterant findings once concentrations meet or exceed validated cutoffs, and DOT-regulated collections generally require re-collection under direct observation once a specimen is called substituted or adulterated. Readers navigating a dilute result in a court context can find a fuller breakdown in this step-by-step defense checklist.
What Does a Medical Review Officer Actually Verify?
A confirmed positive at or above the confirmatory cutoff still isn’t the final word. Federal programs require a Medical Review Officer, a licensed physician trained in substance abuse testing, to review the lab report, check for legitimate prescriptions, and interview the donor before the result becomes official. The ASAM’s clinical guidance puts it plainly: a cutoff tells you whether a specimen crossed a reporting threshold, not whether someone was impaired, when they used a substance, or how much they took.
SAMHSA’s own case studies make that distinction concrete:
A morphine confirmatory result at or above 4,000 ng/mL exceeds concentrations typically seen from poppy seed ingestion, supporting a verified positive rather than a dietary explanation.
That single number, drawn from SAMHSA’s 2025 MRO case studies, is why the 15,000 ng/mL quantitative reporting threshold for morphine and codeine matters. It gives MROs a documented basis for separating genuine opioid use from a bagel with poppy seeds on it.
Pro Tip: If you take a prescribed opioid, benzodiazepine, or stimulant, bring the actual prescription bottle or a pharmacy printout to your MRO interview. Verbal claims without documentation slow down verification and can leave a result flagged longer than it needs to be.
What Detection Window and Concentration Factors Matter?
Detection windows vary more than most people expect, and cutoff concentration is only part of the story. Marijuana metabolite can show up anywhere from a few days after occasional use to several weeks for chronic, heavy users, since THCA stores in fat tissue and releases slowly. Cocaine’s benzoylecgonine marker typically clears within two to four days for casual use. Opioids generally fall in a one to three day window unless the person is a long-term user.
Several factors push measured concentrations up or down independent of how much someone actually used:
- Hydration status dilutes urine and can pull a borderline result below cutoff.
- Metabolism and renal function determine how fast the body clears a substance.
- Dose and chronicity (a single use versus daily use) change how long metabolites stay detectable.
- Assay cross-reactivity means certain over-the-counter or prescribed medications can trigger an immunoassay screen without any illicit substance present.
- Poppy seed consumption can push morphine and codeine above the initial screening cutoff, though rarely near the 4,000 ng/mL or 15,000 ng/mL thresholds MROs use to rule that out.
Quick Reference: Common Analyte Cutoffs
For readers who just need the numbers in one place, here’s the compact version pulled from the federal table and corroborated against clinical references:
These figures govern DOT-regulated testing specifically. Clinical settings sometimes apply different cutoffs, and the NCBI recommended cutoff tables show some variation for non-regulated contexts. Always confirm which program authorized the test before assuming a number applies to a specific case.
Why Cutoff Numbers Matter in Court and Diversion Cases
Numbers alone rarely win a diversion argument, so understanding your rights after a workplace drug test can be critical. What matters is whether the paper trail behind them holds up: which program authorized the test, whether the collection followed chain-of-custody procedures, and whether an MRO actually verified the result rather than a raw lab printout getting forwarded straight to a judge. A dilute or adulterated flag without context reads very differently to a court than one accompanied by documentation explaining hydration, medication, or a legitimate medical procedure.
Anyone preparing for a hearing should collect prescriptions in advance, log any recent medical procedures, and request split-specimen testing when the stakes justify it. That groundwork is exactly what turns a lab report into evidence a defense team can actually use.
— Jake
Getting Court-Ready Documentation Without the Guesswork
Executive Treatment Solutions builds the testing and documentation record before the court asks for it, not after. Where a standalone lab visit hands you a printout and nothing else, our process pairs court-admissible drug screening with case management that tracks chain of custody, MRO verification, and progress reporting your attorney can hand directly to a judge.
That matters most in diversion-eligible cases, PC 1000, Judicial Diversion, Mental Health Diversion, where a single unexplained dilute result or a missing prescription record can stall an otherwise strong petition. Executive Treatment Solutions coordinates testing, therapy, and reporting under one case file so nothing falls through the gap between the lab and the courtroom. If you or someone you’re representing needs testing that holds up under scrutiny, start with pretrial mitigation and court advocacy to see how the documentation process fits your specific case timeline.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Sources
- eCFR :: 49 CFR 40.85 – What are the cutoff concentrations for urine drug tests?
- Recommended Cutoff Levels for Initial Tests – NCBI
FAQ
What Does a Cutoff Level of 50 ng/mL Mean?
A cutoff of 50 ng/mL means a specimen must reach that concentration before a screening test reports it as non-negative. This is the exact initial screening threshold used for THCA (marijuana metabolite) under federal DOT rules; anything measuring below it is reported negative regardless of prior use.
What Are Normal Levels on a Urine Drug Test?
“Normal” in this context means below the initial cutoff for every tested analyte, since a negative screen simply reflects concentrations that never crossed the reporting threshold. Specimen-validity parameters like creatinine and specific gravity also need to fall within expected ranges, or the sample gets flagged as dilute, substituted, or adulterated rather than a clean negative.
How Long Does It Take to Get Results Below 150 ng/mL?
Turnaround time depends on the lab and testing program, but most immunoassay screens return results quickly, with confirmatory GC-MS or LC-MS/MS testing adding additional business days when a specimen meets or exceeds the initial cutoff. A benzoylecgonine result below 150 ng/mL, the initial cutoff for cocaine metabolite, typically reports negative on the faster screening timeline without needing confirmation.
What Cutoff Levels Do Commercial Labs Use?
Cutoff levels vary by lab and by which program authorized the test, since commercial and clinical labs aren’t always bound by the same federal table that governs DOT-regulated testing. The safest approach is to confirm which regulatory standard applies to your specific case rather than assuming any single lab’s public cutoff list applies universally.
Does Executive Treatment Solutions Provide Court-Admissible Testing?
Yes. Executive Treatment Solutions offers court-admissible drug screening built around the documentation, chain-of-custody, and MRO verification standards that courts and diversion programs expect. Pricing details are available through the service page.
